Page last updated: 2024-09-05

tolvaptan and bibw 2992

tolvaptan has been researched along with bibw 2992 in 1 studies

Compound Research Comparison

Studies
(tolvaptan)
Trials
(tolvaptan)
Recent Studies (post-2010)
(tolvaptan)
Studies
(bibw 2992)
Trials
(bibw 2992)
Recent Studies (post-2010) (bibw 2992)
9671727861,0441471,007

Protein Interaction Comparison

ProteinTaxonomytolvaptan (IC50)bibw 2992 (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.0361
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)0.0168
Cytochrome P450 1A2Homo sapiens (human)0.037
Cytochrome P450 2E1Homo sapiens (human)0.014
Cytochrome P450 2C8Homo sapiens (human)0.037
Receptor tyrosine-protein kinase erbB-3Homo sapiens (human)0.0007
Cytochrome P450 2C19Homo sapiens (human)0.037
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.0016
Receptor tyrosine-protein kinase erbB-4Homo sapiens (human)0.0024

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koch, M; Schulz, C; Utpatel, K1

Other Studies

1 other study(ies) available for tolvaptan and bibw 2992

ArticleYear
[Hyponatremia in a 58-year-old female patient with EGFR-positive lung adenocarcinoma].
    Der Internist, 2018, Volume: 59, Issue:4

    Topics: Adenocarcinoma of Lung; Afatinib; Biopsy; Bronchoscopy; Cell Transformation, Neoplastic; Disease Progression; DNA Mutational Analysis; DNA-Binding Proteins; ErbB Receptors; Female; Humans; Hyponatremia; Lung; Lung Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Tomography, X-Ray Computed; Transcription Factors

2018